Immature platelets in patients with acute coronary syndromes
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Summary: Platelets newly released from the bone marrow are RNA-containing and more haemostatically active than mature platelets. Immature platelets are reliably quantified by flow cytometry, and the immature platelet fraction (IPF) reflects platelet production and the rate of platelet turnover. It was the objective of this study to evaluate the presence of immature platelets in healthy subjects, patients with stable coronary artery disease (CAD) and patients with acute coronary syndromes. Flow cytometric determination of immature platelets was performed with an automated analyzer (Sysmex XE-2100) using RNA fluorescent dyes. IPF was determined in 420 individuals: 22 healthy subjects, 39 patients with stable CAD, 182 patients with unstable angina/ non-ST-segment elevation myocardial infarction (non-STEMI) and 177 patients with acute STEMI. The geometric mean [95% confidence interval] of IPF was 2.51 [2.04–3.10] in healthy subjects, 2.87 [2.45–3.36] in CAD patients, 2.93 [2.72–3.15] in the non-STEMI/unstable angina group and 3.71 [3.45–3.99] in patients with STEMI (ANOVA: p < 0.0001). This difference remained significant after adjusting for baseline characteristics (p = 0.0003). In active smokers, IPF was 18% higher than in non-smoking individuals (p = 0.007), and IPF was 16% higher in diabetics compared with non-diabetics (p = 0.060). In conclusion, the fraction of immature platelets is increased in acute coronary syndromes, especially in the acute phase of STEMI. Immature platelets with an increased haemostatic potential may contribute to coronary thrombus formation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increased platelet clearance results in a reduced platelet life span and a relative preponderance of large, immature circulating platelets.34,35”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [35]
Citations
Cites
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Aspirin “resistance” and risk of cardiovascular morbidity: systematic review and meta-analysis
Krasopoulos, G., Brister, S. J., Beattie, W. S., & Buchanan, M. R. (2008) · BMJ · doi:10.1136/bmj.39430.529549.be · Cited by 708
Martin, J. F., Trowbridge, E. A., Salmon, G., & Plumb, J. (1983) · Thrombosis Research · doi:10.1016/0049-3848(83)90255-4 · Cited by 466
Snoep, J. D. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.15.1593 · Cited by 412
Thompson, C. B., Eaton, K. A., Princiotta, S. M., Rushin, C. A., & Valeri, C. R. (1982) · British Journal of Haematology · doi:10.1111/j.1365-2141.1982.tb01947.x · Cited by 375
Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia
Briggs, C., Kunka, S., Hart, D., Oguni, S., & Machin, S. J. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04987.x · Cited by 354
Ault, K. A., Rinder, H. M., Mitchell, J., Carmody, M. B., Vary, C. P. H., & Hillman, R. S. (1992) · American Journal of Clinical Pathology · doi:10.1093/ajcp/98.6.637 · Cited by 260
Variable Platelet Response to Aspirin and Clopidogrel in Atherothrombotic Disease
Maree, A. O., & Fitzgerald, D. J. (2007) · Circulation · doi:10.1161/circulationaha.106.675991 · Cited by 211
Changes in volume and density of platelets in myocardial infarction.
Martin, J. F., Plumb, J., Kilbey, R. S., & Kishk, Y. T. (1983) · BMJ · doi:10.1136/bmj.287.6390.456 · Cited by 201
Determinants of the interindividual variability in response to antiplatelet drugs
Rocca, B., & Patrono, C. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01380.x · Cited by 89
Cited by
Joseph, J. J., Deedwania, P., Acharya, T., Aguilar, D., Bhatt, D. L., Chyun, D. A., Di Palo, K. E., Golden, S. H., Sperling, L. S., & on behalf of the American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Arteriosclerosis, T. A. V. B. C. O. C. C. A. C. O. H. (2022) · Circulation · doi:10.1161/cir.0000000000001040 · Cited by 660
Sørensen, R., Hansen, M. L., Abildstrom, S. Z., Hvelplund, A., Andersson, C., Jørgensen, C., Madsen, J. K., Hansen, P. R., Køber, L., Torp-Pedersen, C., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61751-7 · Cited by 575
Arnold, S. V., Bhatt, D. L., Barsness, G. W., Beatty, A. L., Deedwania, P. C., Inzucchi, S. E., Kosiborod, M., Leiter, L. A., Lipska, K. J., Newman, J. D., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000766 · Cited by 304
Reticulated platelets: analytical aspects and clinical utility
Hoffmann, J. J. M. L. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-0165 · Cited by 154
The causal role of megakaryocyte–platelet hyperactivity in acute coronary syndromes
Martin, J. F., Kristensen, S. D., Mathur, A., Grove, E. L., & Choudry, F. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.131 · Cited by 154
Self-citationPlatelet function in rheumatoid arthritis: arthritic and cardiovascular implications
Gasparyan, A. Y., Stavropoulos‐Kalinoglou, A., Mikhailidis, D. P., Douglas, K., & Kitas, G. D. (2010) · Rheumatology International · doi:10.1007/s00296-010-1446-x · Cited by 162
“These platelets produce proteins, which lead to clot formation [31].”
BackgroundAssociation of Immature Platelets With Adverse Cardiovascular Outcomes
Ibrahim, H., Schutt, R. C., Hannawi, B., DeLao, T., Barker, C. M., & Kleiman, N. S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.06.1210 · Cited by 157
“Previous cross-sectional studies have reported an increase in the proportion of immature platelets in the setting of acute thrombotic events (30,31).”
BackgroundKlovaite, J., Benn, M., Yazdanyar, S., & Nordestgaard, B. G. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04110.x · Cited by 150
Cesari, F., Gori, A. M., Caporale, R., Fanelli, A., Casola, G., Balzi, D., Barchielli, A., Valente, S., Giglioli, C., Gensini, G., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-09-0709 · Cited by 160
Grove, E. L., Hvas, A., MORTENSEN, S. B., Larsen, S., & Kristensen, S. D. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04115.x · Cited by 142
Self-citationPlatelet biology and function: plaque erosion vs. rupture
Baaten, C. C. F. M. J., Nagy, M., Bergmeier, W., Spronk, H. M. H., & van der Meijden, P. E. J. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad720 · Cited by 156
Pons, I., Monteagudo, M., Lucchetti, G. E., Muñoz, L., Perea, G., Colomina, I., Guiu, J., & Obiols, J. (2010) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2010.01468.x · Cited by 110
“Recent studies support the usefulness of IPF determination in other pathologies, such as acute coronary syndrome, which shows an increase in IPF values, especially in the acute phase of myocardial infarction with ST-segment elevation, associating with increased hemostatic potential that contributes to the formation of…”
ResultSansanayudh, N., Muntham, D., Yamwong, S., McEvoy, M., Attia, J. R., Sritara, P., Thakkinstian, A., & Numthavaj, P. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-04-0280 · Cited by 107
“The findings are in agreement with previous publication (69, 70).”
ResultPlatelet activation and inhibition in polycythemia vera and essential thrombocythemia
Patrono, C., Rocca, B., & Stefano, V. D. (2013) · Blood · doi:10.1182/blood-2012-10-429134 · Cited by 104
Biomarkers of platelet activation in acute coronary syndromes
Ferroni, P., Riondino, S., Vazzana, N., Santoro, N., Guadagni, F., & Davì, G. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-08-0550 · Cited by 99
“Similarly, IPF is significantly elevated in patients with STEMI (150).”
BackgroundInfluentialAntiplatelet resistance in stroke
Topçuoğlu, M. A., Arsava, E. M., & Ay, H. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.203 · Cited by 105
Bernlochner, I., Goedel, A., Plischke, C., Schüpke, S., Haller, B., Schulz, C., Mayer, K., Morath, T., Braun, S., Schunkert, H., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv326 · Cited by 85
“As a result, production of RPs is increased in ACS patients.(11,12) Of note, platelet response to the thienopyridines clopidogrel and prasugrel is significantly decreased in dependence of platelet turnover and the amount of circulating RPs resulting in a worse clinical outcome in these patients.”
BackgroundRed cell distribution width and mean platelet volume in patients with irritable bowel syndrome
Aktaş, G., Alçelik, A., Tekçe, B. K., Tekelioğlu, V., Şit, M., & Şavlı, H. (2014) · Gastroenterology Review · doi:10.5114/pg.2014.43578 · Cited by 85
“Activated platelets are involved in the inflammatory processes of various disorders [11–14].”
BackgroundWürtz, M., Grove, E. L., Wulff, L. N., Kaltoft, A., Tilsted, H. H., Jensen, L. O., Hvas, A., & Kristensen, S. D. (2010) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2010.05.014 · Cited by 73
Self-citationStrauß, G., Vollert, C., von Stackelberg, A., Weimann, A., Gaedicke, G., & Schulze, H. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22907 · Cited by 72
“Several studies have attempted to determine whether or not some of these parameters can be used to distinguishbetweendifferentcausesof thrombocytopenia,mostlyby comparing a cohort of sick adults with healthy controls [13,16,17].”
BackgroundPanova‐Noeva, M., Marchetti, M., Buoro, S., Russo, L., Leuzzi, A., Finazzi, G., Rambaldi, A., Ottomano, C., Cate, H. T., & Falanga, A. (2011) · Blood · doi:10.1182/blood-2011-02-339655 · Cited by 71
“in acute coronary syndromes and in cardioembolic stroke.(4,11) In addition, increased % of IPF and H-IPF has been associated with increased platelet aggregation in high risk patients with coronary artery disease.”
BackgroundBonten, T. N., Saris, A., van Oostrom, M. J., Snoep, J. D., Rosendaal, F. R., Zwaginga, J., Eikenboom, J., van der Bom, J. G., & van der Bom, J. G. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-05-0453 · Cited by 74
Larsen, S. B., Grove, E. L., Hvas, A., & Kristensen, S. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085566 · Cited by 69
“This is consistent with previous studies reporting increased IPF in smokers compared with non-smokers [15,46].”
BackgroundResultInfluentialSelf-citationMORTENSEN, S. B., Larsen, S., Grove, E. L., Kristensen, S. D., & Hvas, A. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.03.013 · Cited by 73
“Diabetics might also have an increased platelet turnover and be hypersensitive to pro-aggregatory agonists causing an increased platelet activation and aggregation [38–40].”
BackgroundSelf-citationStratz, C., Bömicke, T., Younas, I., Kittel, A., Amann, M., Valina, C. M., Nührenberg, T. G., Trenk, D., Neumann, F., & Hochholzer, W. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.04.056 · Cited by 68
Würtz, M., & Grove, E. L. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212803251925 · Cited by 74
“Moreover, platelet turnover increases from healthy individuals over stable CAD patients and non-ST-elevation MI patients to reach a maximum in patients with ST-elevation MI [131].”
BackgroundSelf-citationAspirin Resistance: Current Status and Role of Tailored Therapy
Grinstein, J., & Cannon, C. P. (2012) · Clinical Cardiology · doi:10.1002/clc.22031 · Cited by 70
Clopidogrel withdrawal: Is there a “rebound” phenomenon?
Sambu, N., Warner, T. D., & Curzen, N. P. (2010) · Thrombosis and Haemostasis · doi:10.1160/th10-08-0554 · Cited by 68
Ibrahim, H., Nadipalli, S., DeLao, T., Guthikonda, S., & Kleiman, N. S. (2011) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-011-0665-7 · Cited by 62
Mean Platelet Volume in Nasal Polyps
Aktaş, G., Şit, M., Tekçe, H., Alçelik, A., Savli, H., Şimşek, T., Ozmen, E., Isci, A. Z., & Apuhan, T. (2013) · West Indian Medical Journal · doi:10.7727/wimj.2013.011 · Cited by 61
“They have cytoplasmic granules that contain several substantial inflammatory products, such as platelet activation factor (PAF), platelet-derived growth factor (PDGF), platelet factor 4 (PF4), beta-thromboglobulin (b-TG), interleukin-1 (IL-1), leukotriens and prostaglandins (9, 10).”
BackgroundHille, L., Lenz, M., Vlachos, A., Grüning, B. A., Hein, L., Neumann, F., Nührenberg, T. G., & Trenk, D. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14895 · Cited by 66
Gruber, S. C., Grove, E. L., Weiss, T. W., Wojta, J., Huber, K., & Freynhofer, M. K. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-02-0179 · Cited by 62
“The RPF was significantly different, with a stepwise increase between healthy controls, patients with stable CAD, patients with non ST-elevation myocardial infarction and ST-elevation myocardial infarction (74).”
BackgroundSelf-citationBarrabés, J. A., Inserte, J., Mirabet, M., Quiroga, A. G., Hernando, V., Figueras, J., & David Garcia-dorado, A. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-07-0440 · Cited by 55
“On the other hand, circulating platelets are activated by ischaemia and reperfusion (6, 9, 11–15) and their activation status correlates with myocardial damage both in patients (12, 14, 16) and laboratory animals (6, 9, 15).”
BackgroundHaemostatic profiles assessed by thromboelastography in patients with end-stage renal disease
Darlington, A., Ferreiro, J. L., Ueno, M., Suzuki, Y., Desai, B., Capranzano, P., Capodanno, D., Tello‐Montoliu, A., Bass, T. A., Norris, S. N., et al. (2011) · Thrombosis and Haemostasis · doi:10.1160/th10-12-0785 · Cited by 51
“In addition, smoking was found to be an independent predictor of a hyperaggregable status, which confirms data from prior investigations (16, 17).”
ResultRole of Reticulated Platelets in Cardiovascular Disease
Bongiovanni, D., Han, J., Klug, M., Kirmes, K., Viggiani, G., von Scheidt, M., Schreiner, N., Condorelli, G., Laugwitz, K.-L., & Bernlochner, I. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316244 · Cited by 49
Immature platelets: a review of the available evidence
Benlachgar, N., Doghmi, K., Masrar, A., Mahtat, E. M., Harmouche, H., & Tazi, Z. M. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.06.048 · Cited by 48
Proteomic changes related to “bewildered” circulating platelets in the acute coronary syndrome
López-Farré, A. J., Zamorano‐León, J. J., Azcona, L. J., Modrego, J., Mateos‐Cáceres, P. J., González-Armengol, J. J., Villarroel, P., Moreno‐Herrero, R., Rodríguez‐Sierra, P., Segura, A., et al. (2011) · PROTEOMICS · doi:10.1002/pmic.201000708 · Cited by 46
“platelets [4], a low number of platelets to be probably reflected in the proteomic analysis.”
BackgroundInfluentialPlatelets in Myocardial Ischemia/Reperfusion Injury
Schanze, N., Hamad, M. A., Nührenberg, T. G., Bode, C., & Duerschmied, D. (2022) · Hämostaseologie · doi:10.1055/a-1739-9351 · Cited by 50
Hammer, H., Bührer, C., Dame, C., Cremer, M., & Weimann, A. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-03-0148 · Cited by 44
Platelet turnover predicts outcome after coronary intervention
Iliev, L., Bruno, V., Rohla, M., Egger, F., Weiss, T., Hübl, W., Willheim, M., Wojta, J., Huber, K., & Freynhofer, M. K. (2017) · Thrombosis and Haemostasis · doi:10.1160/th16-10-0785 · Cited by 43
“Cesari et al. recently investigated the association of RPF with cardiovascular death in a cohort of 229 ACS patients.”
BackgroundInfluentialImmature platelet fraction in diabetes mellitus and metabolic syndrome
Lee, E. Y., Kim, S. J., Song, Y. J., Choi, S. J., & Song, J. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.09.035 · Cited by 46
“MPV and IPF are convenient markers of platelet activity measured by an automated hematology analyzer [21,22], and MPV has been shown to be increased in CVD.”
BackgroundMethodTekbaş, E., Kara, A. F., Arıtürk, Z., Çil, H., İslamoğlu, Y., Elbey, M. A., Soydinç, S., & Ülgen, M. S. (2011) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2011.599416 · Cited by 41
Mario, A. D., Garzia, M., Leone, F., Arcangeli, A., Pagano, L., & Zini, G. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.07.007 · Cited by 46
24-hour antiplatelet effect of aspirin in patients with previous definite stent thrombosis
Würtz, M., Hvas, A., Jensen, L. O., Kaltoft, A., Tilsted, H. H., Kristensen, S. D., & Grove, E. L. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.05.013 · Cited by 38
“Complete blood counts were assessed using automated flow cytometry (Sysmex XE-5000; Sysmex Kobe, Japan) as previously described [23].”
MethodSelf-citationFaber, J., Hvas, A., Kristensen, S. D., Grove, E. L., & Adelborg, K. (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1721386 · Cited by 44
Self-citationClinical applicability of reticulated platelets
Dusse, L. M. S., & Freitas, L. G. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.10.024 · Cited by 39
Platelet count and indices as postpartum hemorrhage risk factors: a retrospective cohort study
van Dijk, W. E. M., Nijdam, J. S., Haitjema, S., de Groot, M., Huisman, A., Punt, M. C., Evers, A. C. C., Schutgens, R. E. G., Lely, A. T., & van Galen, K. P. M. (2021) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15481 · Cited by 45
Antiplatelet therapy in acute coronary syndromes
Grove, E. L., Würtz, M., Thomas, M. R., & Kristensen, S. D. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1079619 · Cited by 39
“Our growing understanding of atherothrombosis and the pathways involved in adhesion, activation and aggregation of platelets will facilitate identification of new targets for antiplatelet drugs, and both production and turnover of platelets as well as the regulation of thrombopoiesis will also be explored [105,106].”
BackgroundSelf-citationIncreased platelet aggregation and turnover in the acute phase of ST-elevation myocardial infarction
Funck, K. L., Dalsgaard, J., Grove, E. L., Hvas, A., & Kristensen, S. D. (2012) · Platelets · doi:10.3109/09537104.2012.738838 · Cited by 38
“Previously, we have demonstrated that platelet turnover is significantly higher in the acute phase of STEMI compared with healthy individuals and patients with stable coronary artery disease or non-STEMI/unstable angina [16].”
BackgroundMethodInfluentialSelf-citationPolińska, B., Matowicka-Karna, J., & Kemona, H. (2011) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.2011.0017 · Cited by 36
Allan, H. E., Vadgama, A., Armstrong, P. C. J., & Warner, T. D. (2022) · Thrombosis Research · doi:10.1016/j.thromres.2022.12.004 · Cited by 35
Platelet pathophysiology, pharmacology, and function in coronary artery disease
Ibrahim, H., & Kleiman, N. S. (2017) · Coronary Artery Disease · doi:10.1097/mca.0000000000000519 · Cited by 39
Kissová, J., Buliková, A., Ovesná, P., Bourková, L., & Penka, M. (2014) · International Journal of Hematology · doi:10.1007/s12185-014-1673-0 · Cited by 34
Christensen, K. H., Grove, E. L., Würtz, M., Kristensen, S. D., & Hvas, A. (2014) · Platelets · doi:10.3109/09537104.2014.901497 · Cited by 33
“platelet volume were measured using a haematology analyzer (Sysmex XE-5000, Kobe, Japan), allowing flow cytometric determination of platelet parameters as previously described [19].”
BackgroundMethodSelf-citationA brief review on high on-aspirin residual platelet reactivity
Pettersen, A. R., Arnesen, H., & Seljeflot, I. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.03.018 · Cited by 37
Update on Oral Antiplatelet Therapy: Principles, Problems and Promises
Grove, E. L., & Kristensen, S. D. (2009) · Future Cardiology · doi:10.2217/fca.09.10 · Cited by 33
“Interestingly, the fraction of immature platelets is increased in patients with ACS, especially in the acute phase of STEMI, compared with patients with stable coronary artery disease (CAD) and healthy v olunteers [31].”
BackgroundResultSelf-citationPrimary and secondary prevention of cardiovascular disease in diabetes with aspirin
Schnell, O., Erbach, M., & Hummel, M. (2012) · Diabetes and Vascular Disease Research · doi:10.1177/1479164112441486 · Cited by 35
Anetsberger, A., Blobner, M., Haller, B., Schmid, S., Umgelter, K., Hager, T., Langgartner, C., Kochs, E. F., Laugwitz, K., Jungwirth, B., et al. (2017) · Thrombosis and Haemostasis · doi:10.1160/th16-10-0804 · Cited by 34
“In particular, immature platelet fraction (IPF) has been shown to be elevated in patients with acute coronary syndrome (6, 7).”
BackgroundPathophysiology of COVID-19: Critical Role of Hemostasis
de Andrade, S. A., Souza, D. A. D., Torres, A. L., Lima, C. F. G., Ebram, M. C., Celano, R. M. G., Schattner, M. A., & Chudzinski‐Tavassi, A. M. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.896972 · Cited by 38
Clinical utility of mean platelet volume and immature platelet fraction in acute coronary syndrome
Huang, H.-L., Chen, C., Kung, C., Li, Y., Sung, P., You, H.-L., Lin, Y., & Huang, W. (2019) · Biomedical Journal · doi:10.1016/j.bj.2018.12.005 · Cited by 31
“Of notice, it has been shown that ACS patients have higher IPF compared to healthy subjects [33].”
BackgroundReticulated Platelets—Which Functions Have Been Established by In Vivo and In Vitro Data?
Hamad, M. A., Schanze, N., Schommer, N., Nührenberg, T. G., & Duerschmied, D. (2021) · Cells · doi:10.3390/cells10051172 · Cited by 31
“Not only in relation to healthy controls, another study showed that RPs were particularly elevated in STEMI patients compared to other types of acute coronary syndromes [70].”
ResultThe role of immature platelet fraction in acute coronary syndrome
González-Porras, J., Martín-Herrero, F., González-López, T., Olazábal, J., Díez-Campelo, M., Pabón, P., Alberca, I., & Miguel, J. S. S. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-02-0124 · Cited by 33
“Recently, Grove et al showed that measurements of IPF made with the Sysmex XE-2100 were significantly higher in patients with ACS than in healthy subjects (9), although further studies were required.”
ResultInfluentialVerdoia, M., Pergolini, P., Nardin, M., Rolla, R., Barbieri, L., Schaffer, A., Marino, P. N., Bellomo, G., Suryapranata, H., & Luca, G. D. (2016) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-016-1348-1 · Cited by 32
Evaluation of an Alternative Staining Method Using SYTO 13 to Determine Reticulated Platelets
Hille, L., Cederqvist, M., Hromek, J., Stratz, C., Trenk, D., & Nührenberg, T. G. (2019) · Thrombosis and Haemostasis · doi:10.1055/s-0039-1681101 · Cited by 30
Nührenberg, T. G., A�mann, M., Cederqvist, M., Kleiner, P., Valina, C. M., Trenk, D., Neumann, F., Hochholzer, W., & Stratz, C. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-03-0191 · Cited by 32
“It has been shown that patients with acute coronary syndromes have elevated levels of reticulated platelets (5) and that elevated levels of these cells are associated with worse clinical outcome (6, 7).”
BackgroundPatrick, J., Dillaha, L., Armas, D. R., & Sessa, W. C. (2015) · Postgraduate Medicine · doi:10.1080/00325481.2015.1050341 · Cited by 28
“patients with type 2 diabetes or coronary artery disease), this rate can be higher, resulting in new COX-1 activity in newly synthesized platelets and downstream TXA2 production beyond the ASA residence time in plasma and prior to the next dose of ASA [13-16].”
Backgroundvan Diemen, J. J. K., Fuijkschot, W. W., Wessels, T. J., Veen, G., Smulders, Y. M., & Thijs, A. (2015) · Platelets · doi:10.3109/09537104.2015.1107536 · Cited by 28
Ibrahim, H., Nadipalli, S., Usmani, S., DeLao, T., Green, L., & Kleiman, N. S. (2016) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-016-1338-3 · Cited by 28
“Given the variability in staining techniques and incubation times that encumber flow cytometry assessment of TO, a shift towards automated detection of RP has been proposed [13, 14].”
BackgroundIncreased platelet turnover in patients with previous definite stent thrombosis
Grove, E. L., Würtz, M., Hvas, A., & Kristensen, S. D. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04304.x · Cited by 25
Self-citationPatti, G., Proscia, C., & Sciascio, G. D. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0742 · Cited by 27
Antiplatelet effect of aspirin in patients with coronary artery disease.
Grove, E. L. (2012) · PubMed · Cited by 30
Self-citationNeergaard‐Petersen, S., Hvas, A., Grove, E. L., Larsen, S. B., Gregersen, S., & Kristensen, S. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132629 · Cited by 24
“A strength of our study was the simultaneous evaluation of MPV, IPC and IPF since these markers have all been associated with platelet turnover and thrombotic events [19,46].”
MethodSelf-citationImmature platelets in patients with Covid-19: association with disease severity
Cohen, A., Harari, E., Yahud, E., Cipok, M., Bryk, G., Lador, N. K., Mann, T., Mayo, A., & Lev, E. I. (2021) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-021-02560-x · Cited by 23
Verdoia, M., Sartori, C., Pergolini, P., Nardin, M., Rolla, R., Barbieri, L., Schaffer, A., Marino, P. N., Bellomo, G., Suryapranata, H., et al. (2015) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-015-1279-2 · Cited by 23
“Previous studies have associated the rate of IPF with premature coronary artery disease, acute cardiovascular events and with impaired response to antiplatelet agents, as thienopyridines [15–17].”
BackgroundBerny‐Lang, M. A., Darling, C. E., Frelinger, A. L., Barnard, M. R., Smith, C. S., & Michelson, A. D. (2014) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12250 · Cited by 23
“In contrast to two studies that found differences in IPF between patients with ACS [15, 16], the present study did not detect differences in IPF between STEMI, NSTEMI, or unstable angina patients.”
BackgroundResultInfluence of renal function and platelet turnover on the antiplatelet effect of aspirin
Würtz, M., Wulff, L. N., Grove, E. L., Kristensen, S. D., & Hvas, A. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.07.019 · Cited by 23
“in healthy individuals [12,35], in patients with stable CAD [13], in acute coronary syndromes [18], and in patients with previous stent thrombosis [36].”
BackgroundMethodInfluentialSelf-citationAspirin twice a day keeps new COX‐1 at bay
Lordkipanidzé, M., & Harrison, P. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04764.x · Cited by 22
Reticulated Platelets in Medicine: Current Evidence and Further Perspectives
Corpataux, N., Franke, K., Kille, A., Valina, C., Neumann, F., Nührenberg, T., & Hochholzer, W. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113737 · Cited by 21
“With respect to the prognostic value of RPs, a subanalysis of the prospective AMI-Florence 2 Study, which included consecutive patients with suspected STEMI, demonstrated for the first time that the IPF is an independent predictor of cardiovascular death within 12 months in patients with ACS undergoing percutaneous co…”
BackgroundAntiplatelet therapy and vascular disease: an update
Buch, M. H., Prendergast, B., & Storey, R. F. (2010) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944710375780 · Cited by 23
“The underlying mechanisms have not been fully ascertained but are almost certainly multifactorial: an interplay of clinical, cellular and genetic factors is likely [Grove et al. 2009].”
BackgroundImmature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study
Rauber, P., Lammert, F., Grotemeyer, K., & Appenrodt, B. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192271 · Cited by 22
Perl, L., Matatov, Y., Koronowski, R., Lev, E. I., & Solodky, A. (2019) · Platelets · doi:10.1080/09537104.2019.1704712 · Cited by 22
Platelet Turnover in Atherothrombotic Disease
Lordkipanidzé, M. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212803251952 · Cited by 20
“3C), the immature platelet fraction (IPF) increased progressively between healthy controls, patients suffering from stable CAD, those having suffered a non ST-elevation ACS (NSTEACS) and those having suffered an ST-elevation MI (STEMI) [153].”
BackgroundReticulated Platelets: Changing Focus from Basics to Outcomes
Hannawi, B., Hannawi, Y., & Kleiman, N. S. (2018) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1667338 · Cited by 21
Nardin, M., Verdoia, M., Negro, F., Rolla, R., Tonon, F., & Luca, G. D. (2019) · European Journal of Clinical Investigation · doi:10.1111/eci.13181 · Cited by 21
Meershoek, A. J. A., Leunissen, T. C., van Waes, J. A. R., van Klei, W. A., Huisman, A., de Groot, M., Hoefer, I. E., van Solinge, W. W., Moll, F. L., & de Borst, G. J. (2019) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2019.06.027 · Cited by 20
Kovács, E., Katona, É., Bereczky, Z., Homoródi, N., Balogh, L., Tóth, E., Péterfy, H., Kiss, R. G., Edes, I. F., & Muszbek, L. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.10.008 · Cited by 19
“3/ A high platelet turnover in some instances results in an accelerated production and release into the circulation of large numbers of newly formed but not yet acetylated platelets [17–19].”
BackgroundElevated Neutrophil Lymphocyte Ratio in Recurrent Optic Neuritis
Güçlü, H., Özal, S. A., Gürlü, V., & Birgül, R. (2015) · Journal of Ophthalmology · doi:10.1155/2015/758687 · Cited by 18
Gurbel, P. A., Bliden, K. P., Chaudhary, R., Patrick, J., Liu, F., Chen, G., McLeod, C. J., & Tantry, U. S. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.08.088 · Cited by 19
Immature Platelet Fraction: A New Prognostic Marker in Acute Coronary Syndrome
López-Jiménez, R. A., Martín‐Herrero, F., González‐Porras, J. R., Sánchez‐Barba, M., Martín‐Luengo, C., & Pabón-Osuna, P. (2012) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2012.05.014 · Cited by 18
Drug Delivery and Therapeutic Impact of extended-release Acetylsalicylic Acid
Bliden, K. P., Patrick, J., Pennell, A. T., Tantry, U. S., & Gurbel, P. A. (2015) · Future Cardiology · doi:10.2217/fca.15.60 · Cited by 19
Immature platelet fraction and the extent of coronary artery disease: A single centre study
Verdoia, M., Nardin, M., Rolla, R., Marino, P. N., Bellomo, G., Suryapranata, H., & Luca, G. D. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.03.044 · Cited by 17
Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease
Pi, L., Che, D., Long, H., Fang, Z., Li, J., Lin, S.-Y., Liu, Y.-F., Li, M., Bao, L., Li, W., et al. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s163705 · Cited by 17
Stratz, C., Nührenberg, T. G., Valina, C. M., Löffelhardt, N., Mashayekhi, K., Ferenc, M., Trenk, D., Neumann, F., & Hochholzer, W. (2018) · Thrombosis and Haemostasis · doi:10.1160/th17-07-0466 · Cited by 19
Parco, S., & Vascotto (2012) · OncoTargets and Therapy · doi:10.2147/ott.s27883 · Cited by 16
Freynhofer, M. K., Bruno, V., Brozovic, I., Grove, E. L., Kristensen, S. D., Willheim, M., Hübl, W., & Huber, K. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-01-0051 · Cited by 16
“Acetylsalicylic acid (ASA) and clopidogrel are beneficial in patients with acute coronary syndromes (ACS) and after percutaneous coronary intervention (PCI) (1).”
BackgroundSelf-citationThe lack of aspirin resistance in patients with coronary artery disease
Homoródi, N., Kovács, E., Leé, S., Katona, É., Shemirani, A. H., Haramura, G., Balogh, L., Bereczky, Z., Szőke, G., Péterfy, H., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0827-7 · Cited by 17
“enough TXA2 to activate platelets, even platelets with acCOX1 [14, 15, 25, 26].”
BackgroundStapley, R. J., Smith, C. W., Haining, E. J., Bacon, A., Lax, S., Pisareva, V. P., Pisarev, A. V., Watson, S. P., Khan, A. O., & Morgan, N. V. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020002404 · Cited by 15
“An elevated platelet RNA content signifies newer platelets in the circulation that was previously shown to increase platelet reactivity in cardiovascular events and mortality.(31) In the case of SLFN14mice, we infer that the slight increase in platelet size is due to their immaturity (determined by SYTO13 staining), b…”
BackgroundImpact of Long-Term Dual Antiplatelet Therapy on Immature Platelet Count and Platelet Reactivity
Verdoia, M., Pergolini, P., Rolla, R., Barbieri, L., Schaffer, A., Marino, P. N., Bellomo, G., Suryapranata, H., & Luca, G. D. (2017) · Angiology · doi:10.1177/0003319717736407 · Cited by 15
Real-World Use of Fostamatinib in Patients with Immune Thrombocytopenia and Thrombotic Risk
Mehta, A. R., Kefela, A., Toste, C., & Sweet, D. L. (2021) · Acta Haematologica · doi:10.1159/000520438 · Cited by 14
Hernández-Suárez, D. F., Botton, M. R., Scott, S. A., Tomey, M. I., Garcia, M. J., Wiley, J. M., Villablanca, P. A., Melín, K., López‐Candales, A., Renta, J. Y., et al. (2018) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s165805 · Cited by 14
“Patients with DM have increased platelet reactivity and a higher percent of circulating immature platelets, 13,47 which could reduce the inhibitory effect of clopidogrel on platelet aggregation.”
Metadata
- Authors
- Hvas, A.-M., Kristensen, S. D., & Grove, E. L.
- Affiliations
- Aarhus University Hospital (DK)
- Corresponding author
- Grove, Erik Lerkevang
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2009
- Volume
- 101
- Issue
- 01
- Pages
- 151-153
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W2127436599
- Cited by
- 202
- References
- 14
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 9 · 2023: 16 · 2022: 7 · 2021: 11 · 2020: 12 · 2019: 11 · 2018: 11 · 2017: 10 · 2016: 11 · 2015: 16 · 2014: 14 · 2013: 10 · 2012: 17
- FWCI
- 7.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Thrombosis and Haemostasis (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Danish Research Agency (2101–05–0052 to ELG and SDK)
- Topics
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Keywords
- immature platelets, immature platelet fraction, acute coronary syndrome, stable coronary artery disease, acute myocardial infarction, unstable angina, platelet turnover, megakaryopoiesis, smoking, diabetes mellitus, coronary thrombus formation, hemostatic activity
- MeSH terms
- Adult, Aged, Aged, 80 and over, Angina, Unstable, Blood Platelets, Coronary Artery Disease, Coronary Thrombosis, Female, Flow Cytometry, Hemostasis, Humans, Male, Middle Aged, Myocardial Infarction, Platelet Count, Risk Factors, Linear Models, Case-Control Studies, Risk Assessment, Thrombopoiesis, Acute Coronary Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.